Skip to content

Atomoxetine

Atomoxetine (Strattera) is a non-stimulant medicine listed for attention deficit hyperactivity disorder, or ADHD, in children and adults. This catalogue contains the Axepta and Strattera tablet formulations.

Axepta

Attention Deficit Hyperactivity Disorder

10mg · 18mg · 25mg · 40mg

Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.

From$0.89/ tabletView

Strattera

Attention Deficit Hyperactivity Disorder

10mg · 18mg · 25mg · 40mg

Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant option that raises norepinephrine levels in the brain.

From$0.79/ tabletView

Key points

  • A norepinephrine reuptake inhibitor is a type of non-stimulant medicine used for ADHD.
  • A boxed warning says children and adolescents starting atomoxetine need close monitoring for suicidal thoughts, behaviour changes or worsening symptoms.
  • Atomoxetine is not approved for major depressive disorder.

Why the boxed warning is included

The warning comes from a pooled analysis of 12 short-term studies involving more than 2,200 children and adolescents with ADHD. Suicidal ideation occurred in five of 1,357 people taking atomoxetine, or 0.4%, and none of 851 placebo participants; no suicides occurred.

Further reading